Skip to main content
Fig. 3 | Cancer Nanotechnology

Fig. 3

From: Targeting and internalizing PEGylated nanodrugs to enhance the therapeutic efficacy of hematologic malignancies by anti-PEG bispecific antibody (mPEG × CD20)

Fig. 3

αCD20-armed liposomes enhance selection and internalization of PLD against CD20 + lymphoma cells. a αCD20/PLD (red) and αDNS/PLD (blue) were incubated with CD20 + Raji cells and b CD20- Molt-3 cells. The particles were measured using flow cytometry with an anti-PEG antibody. c The internalization of αDNS/PLD and d αCD20/PLD into Raji cells. The surface Lipo-DiD was measured using flow cytometry with an anti-PEG antibody. e The DiD uptake of αCD20/PLD in Raji cells was detected using flow cytometry. f The internalization values (%) were determined at different time intervals of incubation

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us